DivestmentJul 7, 2026, 04:31 PM
Resmed Sells MatrixCare Business to Frazier Healthcare Partners
AI Summary
Resmed announced a definitive agreement to sell its MatrixCare business to Frazier Healthcare Partners, a private equity firm focused on healthcare. This divestiture aligns with Resmed's 2030 strategy to concentrate on high-growth, scalable opportunities in sleep health, breathing health, and connected home-based healthcare. The move is expected to strengthen Resmed's ability to reallocate capital and resources towards innovation and long-term value creation. The transaction, which includes MatrixCare and related software offerings, is anticipated to close in the first quarter of Resmed's fiscal year 2027, subject to regulatory approvals.
Key Highlights
- Resmed to sell its MatrixCare business to Frazier Healthcare Partners.
- Divestment aligns with Resmed's 2030 strategy to focus on high-growth opportunities.
- Strengthens Resmed's ability to reallocate capital and resources for innovation.
- MatrixCare provides software solutions to over 15,000 providers in long-term care.
- Transaction includes MatrixCare, Healthcare First, Citus, and home health/hospice solutions.
- Excludes Resmed's other software businesses, Brightree (U.S.) and MEDIFOX DAN (Germany).
- Transaction expected to close during Q1 of Resmed's fiscal year 2027.
Price Impact
More from RMD